$PFHO
PACIFIC HEALTH CARE ORGANIZATION INC

2022 Q3 Form 10-Q Financial Statement

#000118518522000978 Filed on August 22, 2022

View on sec.gov

Income Statement

Concept 2022 Q3 2022 Q2 2022 Q1
Revenue $1.454M $1.400M $1.427M
YoY Change 10.94% 4.24% 7.78%
Cost Of Revenue $239.6K $254.3K $237.6K
YoY Change 14.96% 20.23% 17.76%
Gross Profit $1.214M $1.146M $1.190M
YoY Change 10.18% 1.26% 5.99%
Gross Profit Margin 83.52% 81.84% 83.35%
Selling, General & Admin $937.9K $963.7K $923.5K
YoY Change -4.57% -2.61% -6.66%
% of Gross Profit 77.22% 84.08% 77.62%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $9.661K $9.297K $4.200K
YoY Change -23.63% -13.01% -66.72%
% of Gross Profit 0.8% 0.81% 0.35%
Operating Expenses $1.187M $1.227M $927.6K
YoY Change 19.25% 1.28% -7.42%
Operating Profit $266.9K $173.1K $262.1K
YoY Change 149.87% 31.48% 117.36%
Interest Expense $0.00 $0.00 $0.00
YoY Change -100.0%
% of Operating Profit 0.0% 0.0% 0.0%
Other Income/Expense, Net $2.898K $46.31K $10.19K
YoY Change -75.68% -7.52%
Pretax Income $266.9K $173.1K $262.1K
YoY Change 149.87% 31.48% -54.91%
Income Tax $74.93K $48.59K $73.57K
% Of Pretax Income 28.07% 28.07% 28.07%
Net Earnings $192.0K $124.5K $188.5K
YoY Change 149.84% 31.48% -62.83%
Net Earnings / Revenue 13.21% 8.89% 13.21%
Basic Earnings Per Share $0.02 $0.01 $0.01
Diluted Earnings Per Share $0.01 $0.01 $14.71K
COMMON SHARES
Basic Shares Outstanding 12.80M shares 12.80M shares 12.80M shares
Diluted Shares Outstanding 12.82M shares 12.82M shares 12.82M shares

Balance Sheet

Concept 2022 Q3 2022 Q2 2022 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $10.64M $10.41M $10.54M
YoY Change 4.78% 3.05% 6.35%
Cash & Equivalents $10.64M $10.41M $10.54M
Short-Term Investments
Other Short-Term Assets $157.3K $174.3K $106.3K
YoY Change 110.29% 83.77% 35.47%
Inventory
Prepaid Expenses $157.3K $174.3K
Receivables $864.1K $936.3K $802.3K
Other Receivables $3.000K $3.000K $58.40K
Total Short-Term Assets $11.66M $11.52M $11.51M
YoY Change 5.86% 5.54% 6.2%
LONG-TERM ASSETS
Property, Plant & Equipment $87.00K $96.21K $94.47K
YoY Change -63.43% -69.01% -73.84%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $6.602K $33.39K $33.39K
YoY Change -75.36% 24.64% 24.64%
Total Long-Term Assets $93.60K $129.6K $127.9K
YoY Change -64.63% -61.57% -67.04%
TOTAL ASSETS
Total Short-Term Assets $11.66M $11.52M $11.51M
Total Long-Term Assets $93.60K $129.6K $127.9K
Total Assets $11.76M $11.65M $11.63M
YoY Change 4.2% 3.53% 3.67%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $89.34K $106.6K $61.84K
YoY Change 51.39% 217.21% -36.98%
Accrued Expenses $247.3K $306.0K $366.6K
YoY Change -37.26% -33.76% -30.52%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $421.5K $507.3K $613.4K
YoY Change -28.77% -17.8% -29.34%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change -100.0% -100.0%
Other Long-Term Liabilities $0.00 $0.00 $0.00
YoY Change -100.0%
Total Long-Term Liabilities $0.00 $0.00 $0.00
YoY Change -100.0% -100.0% -100.0%
TOTAL LIABILITIES
Total Short-Term Liabilities $421.5K $507.3K $613.4K
Total Long-Term Liabilities $0.00 $0.00 $0.00
Total Liabilities $428.6K $514.5K $620.5K
YoY Change -44.73% -37.52% -29.87%
SHAREHOLDERS EQUITY
Retained Earnings $10.90M $10.71M
YoY Change
Common Stock $12.80K $12.80K
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $11.33M $11.14M $11.01M
YoY Change
Total Liabilities & Shareholders Equity $11.76M $11.65M $11.63M
YoY Change 4.2% 3.53% 3.67%

Cashflow Statement

Concept 2022 Q3 2022 Q2 2022 Q1
OPERATING ACTIVITIES
Net Income $192.0K $124.5K $188.5K
YoY Change 149.84% 31.48% -62.83%
Depreciation, Depletion And Amortization $9.661K $9.297K $4.200K
YoY Change -23.63% -13.01% -66.72%
Cash From Operating Activities $231.9K -$118.9K $459.4K
YoY Change 278.36% 360.57% 10.82%
INVESTING ACTIVITIES
Capital Expenditures -$450.00 -$11.04K -$6.130K
YoY Change -93.35% 401.82% 89.78%
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities -$450.00 -$11.04K -$6.130K
YoY Change -93.35% 401.82% 89.78%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 0.000 0.000 0.000
YoY Change -100.0%
NET CHANGE
Cash From Operating Activities 231.9K -118.9K 459.4K
Cash From Investing Activities -450.0 -11.04K -6.130K
Cash From Financing Activities 0.000 0.000 0.000
Net Change In Cash 231.4K -130.0K 453.2K
YoY Change 324.53% -168.08% 10.2%
FREE CASH FLOW
Cash From Operating Activities $231.9K -$118.9K $459.4K
Capital Expenditures -$450.00 -$11.04K -$6.130K
Free Cash Flow $232.3K -$107.9K $465.5K
YoY Change 241.38% 356.73% 11.43%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2022Q2 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
13217 usd
CY2021Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
23083 usd
CY2022Q2 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
936347 usd
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2022-06-30
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
000-50009
dei Entity Registrant Name
EntityRegistrantName
PACIFIC HEALTH CARE ORGANIZATION, INC.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
UT
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
87-0285238
dei Entity Address Address Line1
EntityAddressAddressLine1
19800 MacArthur Boulevard
dei Entity Address Address Line2
EntityAddressAddressLine2
Suites 306 & 307
dei Entity Address City Or Town
EntityAddressCityOrTown
Irvine
dei Entity Address State Or Province
EntityAddressStateOrProvince
CA
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
92612
dei City Area Code
CityAreaCode
949
dei Local Phone Number
LocalPhoneNumber
721-8272
dei Security12b Title
Security12bTitle
None
dei No Trading Symbol Flag
NoTradingSymbolFlag
true
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
CY2022Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
12800000 shares
CY2022Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
10408658 usd
CY2021Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
10085372 usd
CY2021Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
927990 usd
CY2022Q2 us-gaap Deferred Rent Asset Net Current
DeferredRentAssetNetCurrent
0 usd
CY2021Q4 us-gaap Deferred Rent Asset Net Current
DeferredRentAssetNetCurrent
10055 usd
CY2022Q2 us-gaap Income Taxes Receivable
IncomeTaxesReceivable
0 usd
CY2021Q4 us-gaap Income Taxes Receivable
IncomeTaxesReceivable
19779 usd
CY2022Q2 us-gaap Other Receivables
OtherReceivables
3000 usd
CY2021Q4 us-gaap Other Receivables
OtherReceivables
3000 usd
CY2022Q2 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
174335 usd
CY2021Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
96977 usd
CY2022Q2 us-gaap Assets Current
AssetsCurrent
11522340 usd
CY2021Q4 us-gaap Assets Current
AssetsCurrent
11143173 usd
CY2022Q2 us-gaap Property Plant And Equipment Other
PropertyPlantAndEquipmentOther
543415 usd
CY2021Q4 us-gaap Property Plant And Equipment Other
PropertyPlantAndEquipmentOther
526249 usd
CY2022Q2 us-gaap Furniture And Fixtures Gross
FurnitureAndFixturesGross
226323 usd
CY2021Q4 us-gaap Furniture And Fixtures Gross
FurnitureAndFixturesGross
226323 usd
CY2022Q2 us-gaap Machinery And Equipment Gross
MachineryAndEquipmentGross
9556 usd
CY2021Q4 us-gaap Machinery And Equipment Gross
MachineryAndEquipmentGross
9556 usd
CY2022Q2 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
779294 usd
CY2021Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
762128 usd
CY2022Q2 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
683084 usd
CY2021Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
669592 usd
CY2022Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
96210 usd
CY2021Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
92536 usd
CY2022Q2 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
0 usd
CY2021Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
70368 usd
CY2022Q2 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
33390 usd
CY2021Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
26788 usd
CY2022Q2 us-gaap Assets
Assets
11651940 usd
CY2021Q4 us-gaap Assets
Assets
11332865 usd
CY2022Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
106550 usd
CY2021Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
44899 usd
CY2022Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
305993 usd
CY2021Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
315495 usd
CY2022Q2 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
14388 usd
CY2021Q4 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
0 usd
CY2022Q2 us-gaap Dividends Payable Current
DividendsPayableCurrent
37000 usd
CY2021Q4 us-gaap Dividends Payable Current
DividendsPayableCurrent
37000 usd
CY2022Q2 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
0 usd
CY2021Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
70368 usd
CY2022Q2 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
43391 usd
CY2021Q4 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
33544 usd
CY2022Q2 us-gaap Liabilities Current
LiabilitiesCurrent
507322 usd
CY2021Q4 us-gaap Liabilities Current
LiabilitiesCurrent
501306 usd
CY2022Q2 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
7154 usd
CY2021Q4 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
7154 usd
CY2022Q2 us-gaap Liabilities
Liabilities
514476 usd
CY2021Q4 us-gaap Liabilities
Liabilities
508460 usd
CY2022Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
0 usd
CY2021Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
0 usd
CY2022Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000 shares
CY2021Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000 shares
CY2022Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2021Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2022Q2 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
16000 shares
CY2021Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
16000 shares
CY2022Q2 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
16000 shares
CY2021Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
16000 shares
CY2022Q2 us-gaap Preferred Stock Value
PreferredStockValue
16 usd
CY2021Q4 us-gaap Preferred Stock Value
PreferredStockValue
16 usd
CY2022Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2021Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2022Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
800000000 shares
CY2021Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
800000000 shares
CY2022Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
12800000 shares
CY2021Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
12800000 shares
CY2022Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
12800000 shares
CY2021Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
12800000 shares
CY2022Q2 us-gaap Common Stock Value
CommonStockValue
12800 usd
CY2021Q4 us-gaap Common Stock Value
CommonStockValue
12800 usd
CY2022Q2 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
416057 usd
CY2021Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
416057 usd
CY2022Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
10708591 usd
CY2021Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
10395532 usd
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
11137464 usd
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
10824405 usd
CY2022Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
11651940 usd
CY2021Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
11332865 usd
CY2022Q2 us-gaap Revenues
Revenues
1400451 usd
CY2021Q2 us-gaap Revenues
Revenues
1343451 usd
us-gaap Revenues
Revenues
2827834 usd
us-gaap Revenues
Revenues
2667813 usd
CY2022Q2 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
9297 usd
CY2021Q2 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
10688 usd
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
13492 usd
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
23307 usd
CY2022Q2 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
0 usd
CY2021Q2 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
494 usd
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
4783 usd
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
494 usd
CY2022Q2 us-gaap Professional And Contract Services Expense
ProfessionalAndContractServicesExpense
56206 usd
CY2021Q2 us-gaap Professional And Contract Services Expense
ProfessionalAndContractServicesExpense
58399 usd
us-gaap Professional And Contract Services Expense
ProfessionalAndContractServicesExpense
110161 usd
us-gaap Professional And Contract Services Expense
ProfessionalAndContractServicesExpense
115522 usd
CY2022Q2 us-gaap Labor And Related Expense
LaborAndRelatedExpense
686240 usd
CY2021Q2 us-gaap Labor And Related Expense
LaborAndRelatedExpense
698985 usd
us-gaap Labor And Related Expense
LaborAndRelatedExpense
1319612 usd
us-gaap Labor And Related Expense
LaborAndRelatedExpense
1393603 usd
CY2022Q2 us-gaap Professional Fees
ProfessionalFees
79774 usd
CY2021Q2 us-gaap Professional Fees
ProfessionalFees
80127 usd
us-gaap Professional Fees
ProfessionalFees
146638 usd
us-gaap Professional Fees
ProfessionalFees
145956 usd
CY2022Q2 us-gaap General Insurance Expense
GeneralInsuranceExpense
75211 usd
CY2021Q2 us-gaap General Insurance Expense
GeneralInsuranceExpense
69111 usd
us-gaap General Insurance Expense
GeneralInsuranceExpense
158877 usd
us-gaap General Insurance Expense
GeneralInsuranceExpense
155807 usd
CY2022Q2 us-gaap Other Cost Of Operating Revenue
OtherCostOfOperatingRevenue
132820 usd
CY2021Q2 us-gaap Other Cost Of Operating Revenue
OtherCostOfOperatingRevenue
92355 usd
us-gaap Other Cost Of Operating Revenue
OtherCostOfOperatingRevenue
276598 usd
us-gaap Other Cost Of Operating Revenue
OtherCostOfOperatingRevenue
194158 usd
CY2022Q2 us-gaap Other Expenses
OtherExpenses
46313 usd
CY2021Q2 us-gaap Other Expenses
OtherExpenses
50080 usd
us-gaap Other Expenses
OtherExpenses
56502 usd
us-gaap Other Expenses
OtherExpenses
63376 usd
CY2022Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
141472 usd
CY2021Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
151540 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
305944 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
323325 usd
CY2022Q2 us-gaap Operating Expenses
OperatingExpenses
1227333 usd
CY2021Q2 us-gaap Operating Expenses
OperatingExpenses
1211779 usd
us-gaap Operating Expenses
OperatingExpenses
2392607 usd
us-gaap Operating Expenses
OperatingExpenses
2415548 usd
CY2022Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
173118 usd
CY2021Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
131672 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
435227 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
252265 usd
CY2022Q2 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
0 usd
CY2021Q2 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
0 usd
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
0 usd
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
464386 usd
CY2022Q2 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
0 usd
CY2021Q2 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
0 usd
us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
0 usd
us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
-3686 usd
CY2022Q2 us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
0 usd
CY2021Q2 us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
0 usd
us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
0 usd
us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
460700 usd
CY2022Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
173118 usd
CY2021Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
131672 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
435227 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
712965 usd
CY2022Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
48594 usd
CY2021Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
36961 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
122168 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
110969 usd
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
124524 usd
CY2021Q2 us-gaap Net Income Loss
NetIncomeLoss
94711 usd
us-gaap Net Income Loss
NetIncomeLoss
313059 usd
us-gaap Net Income Loss
NetIncomeLoss
601996 usd
CY2022Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.01
CY2021Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.01
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.02
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.05
CY2022Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
12800000 shares
CY2021Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
12800000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
12800000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
12800000 shares
CY2022Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.01
CY2021Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.01
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.02
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.05
CY2022Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
12816000 shares
CY2021Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
12816000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
12816000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
12816000 shares
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
9829385 usd
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
507285 usd
CY2021Q1 us-gaap Stockholders Equity
StockholdersEquity
10336670 usd
CY2021Q2 us-gaap Net Income Loss
NetIncomeLoss
94711 usd
CY2021Q2 us-gaap Stockholders Equity
StockholdersEquity
10431381 usd
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
10824405 usd
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
188535 usd
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
11012940 usd
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
124524 usd
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
11137464 usd
us-gaap Net Income Loss
NetIncomeLoss
313059 usd
us-gaap Net Income Loss
NetIncomeLoss
601996 usd
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
13492 usd
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
23307 usd
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
4783 usd
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
494 usd
us-gaap Debt Instrument Increase Decrease For Period Net
DebtInstrumentIncreaseDecreaseForPeriodNet
0 usd
us-gaap Debt Instrument Increase Decrease For Period Net
DebtInstrumentIncreaseDecreaseForPeriodNet
460700 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
13140 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-343551 usd
us-gaap Increase Decrease In Deferred Charges
IncreaseDecreaseInDeferredCharges
-10055 usd
us-gaap Increase Decrease In Deferred Charges
IncreaseDecreaseInDeferredCharges
0 usd
us-gaap Increase Decrease In Other Receivables
IncreaseDecreaseInOtherReceivables
0 usd
us-gaap Increase Decrease In Other Receivables
IncreaseDecreaseInOtherReceivables
-1000 usd
us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
77358 usd
us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
-7833 usd
us-gaap Increase Decrease In Income Taxes Receivable
IncreaseDecreaseInIncomeTaxesReceivable
-19779 usd
us-gaap Increase Decrease In Income Taxes Receivable
IncreaseDecreaseInIncomeTaxesReceivable
0 usd
us-gaap Increase Decrease In Prepaid Taxes
IncreaseDecreaseInPrepaidTaxes
0 usd
us-gaap Increase Decrease In Prepaid Taxes
IncreaseDecreaseInPrepaidTaxes
20203 usd
us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
6602 usd
us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
0 usd
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
61651 usd
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-46544 usd
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-9502 usd
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-18476 usd
us-gaap Increase Decrease In Deferred Liabilities
IncreaseDecreaseInDeferredLiabilities
0 usd
us-gaap Increase Decrease In Deferred Liabilities
IncreaseDecreaseInDeferredLiabilities
6116 usd
us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
9847 usd
us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
12167 usd
us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
14388 usd
us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
-61828 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
340452 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
388713 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
17166 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
5434 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-17166 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-5434 usd
us-gaap Proceeds From Loans
ProceedsFromLoans
0 usd
us-gaap Proceeds From Loans
ProceedsFromLoans
218900 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
0 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
218900 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
323286 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
602179 usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
10085372 usd
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
9498457 usd
CY2022Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
10408658 usd
CY2021Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
10100636 usd
us-gaap Interest Paid Net
InterestPaidNet
0 usd
us-gaap Interest Paid Net
InterestPaidNet
3686 usd
us-gaap Income Taxes Paid
IncomeTaxesPaid
88000 usd
us-gaap Income Taxes Paid
IncomeTaxesPaid
193000 usd
CY2022Q2 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
13217 usd
CY2021Q4 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
23083 usd
CY2015Q3 us-gaap Lessee Operating Lease Term Of Contract
LesseeOperatingLeaseTermOfContract
P79M
CY2015Q3 us-gaap Area Of Real Estate Property
AreaOfRealEstateProperty
9439 sqft
CY2022Q2 us-gaap Lessee Operating Lease Term Of Contract
LesseeOperatingLeaseTermOfContract
P12M
CY2022Q2 us-gaap Area Of Real Estate Property
AreaOfRealEstateProperty
320 sqft
CY2022Q2 us-gaap Operating Lease Expense
OperatingLeaseExpense
11372 usd
CY2021Q2 us-gaap Operating Lease Expense
OperatingLeaseExpense
51459 usd
us-gaap Operating Lease Expense
OperatingLeaseExpense
86956 usd
us-gaap Operating Lease Expense
OperatingLeaseExpense
124405 usd
CY2021Q1 us-gaap Debt Instrument Decrease Forgiveness
DebtInstrumentDecreaseForgiveness
460700 usd
CY2021Q4 us-gaap Debt Instrument Decrease Forgiveness
DebtInstrumentDecreaseForgiveness
218900 usd
dei Amendment Flag
AmendmentFlag
false
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q2
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2022
dei Entity Central Index Key
EntityCentralIndexKey
0001138476

Files In Submission

Name View Source Status
0001185185-22-000978-index-headers.html Edgar Link pending
0001185185-22-000978-index.html Edgar Link pending
0001185185-22-000978.txt Edgar Link pending
0001185185-22-000978-xbrl.zip Edgar Link pending
ex_413878.htm Edgar Link pending
ex_413879.htm Edgar Link pending
ex_413880.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
pacifichco20220630_10q.htm Edgar Link pending
pfho-20220630.xsd Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R2.htm Edgar Link pending
R3.htm Edgar Link pending
R4.htm Edgar Link pending
pfho-20220630_def.xml Edgar Link unprocessable
pfho-20220630_cal.xml Edgar Link unprocessable
pfho-20220630_pre.xml Edgar Link unprocessable
pfho-20220630_lab.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
pacifichco20220630_10q_htm.xml Edgar Link completed
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending